PACILIO, MASSIMILIANO

PACILIO, MASSIMILIANO  

DIPARTIMENTO DI SCIENZE RADIOLOGICHE, ONCOLOGICHE E ANATOMO-PATOLOGICHE  

Mostra prodotti
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.032 secondi).
Titolo Data di pubblicazione Autore(i) File
123I-mibg Imaging For Parkinson’S Disease: The Diagnostic Value Of The Early Heart-to-mediastinum Count Ratio 2018 Frantellizzi, V.; Pacilio, M.; Farcomeni, A.; Borrazzo, C.; DE VINCENTIS, Giuseppe
A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with223Radium-dichloride 2018 Frantellizzi, Viviana; Farcomeni, Alessio; Follacchio, Giulia Anna; Pacilio, Massimiliano; Pellegrini, Rosanna; Pani, Roberto; de Vincentis, Giuseppe
Analysis of Clinical parameters for the outcame prediction of mCRPC patients treated with Ra-223-dichloride 2017 Frantellizzi, V; Follacchio, Ga; Sollaku, S; Lazri, J; Farcomeni, A; Pacilio, M; Liberatore, M; Monteleone, F; De Vincentis, G
Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC)undergoing 223Ra-dichloride Therapy 2016 Follacchio, Ga; Frantellizzi, V; Pacilio, M; Cassano, B; Pani, R; Pellegrini, R; De Vincentis, G
Deep seated tumour treatments with electrons of high energy delivered at FLASH rates: the example of prostate cancer 2021 Sarti, Alessio; De Maria, Patrizia; Battistoni, Giuseppe; De Simoni, Micol; Di Felice, Cinzia; Dong, Yunsheng; Fischetti, Marta; Franciosini, Gaia; Marafini, Michela; Marampon, Francesco; Mattei, Ilaria; Mirabelli, Riccardo; Muraro, Silvia; Pacilio, Massimiliano; Palumbo, Luigi; Rocca, Loredana; Rubeca, Damiana; Schiavi, Angelo; Sciubba, Adalberto; Tombolini, Vincenzo; Toppi, Marco; Traini, Giacomo; Trigilio, Antonio; Patera, Vincenzo
Definition of a Predictive Score to guide therapeutic management in metastatic CRPC patients eligible to Radium-223 2017 Follacchio, Ga; Frantellizzi, V; Pontico, M; DE FEO, MARIA SILVIA; Monteleone, F; Liberatore, M; Farcomeni, A.; Pacilio, M; De Vincentis, G
Diagnostic value of the early heart-to-mediastinum count ratio in cardiac 123I-mIBG imaging for Parkinson's disease 2021 Frantellizzi, Viviana; Lavelli, Valentina; Ferrari, Cristina; Sardaro, Angela; Farcomeni, Alessio; Pacilio, Massimiliano; Borrazzo, Cristian; Pani, Roberto; Rubini, Giuseppe; Vincentis, Giuseppe De
Dose-response correlation in radioiodine therapy of hyperthyroidism from nodular thyroid disease 2017 Pacilio, M; Ventroni, G; Frantellizzi, V; Cassano, B; Verdolino, E; Montesano, T; De Vincentis, G; Mango, L
Feasibility of 223 Ra imaging for clinical purpose 2015 De Vincentis, G; Follacchio, Ga; Frantellizzi, V; Pellegrini, R; Di Castro, E; Pani, R; Garkavaya, T; Caruso, M; Iacobelli, S; Monteleone, F; Liberatore, M; Cassano, B; Lorenzon, L; Mango, L; Ventroni, G; Pacilio, M
Feasibility of 223Ra quantitative imaging for lesion dosimetry 2015 Follacchio, Ga; Frantellizzi, V; Pellegrini, R; Pani, R; Pacilio, M; Cassano, B; Liberatore, M; Monteleone, F; Garkavaya, T; Ventroni, Guido; Mango, L; De Vincentis, G
I-131 differentiated thyroid cancer therapy in pediatric patients based on I-123 pre-therapeutic red marrow dosimetry 2016 Pacilio, M; Orlandi, C; Cannata, V; Donatiello, S; Garganese, Mc; Genovese, E; Lorenzon, L; Pizzoferro, M; Villani, Mf; Longo, M
Immunoscintigraphy for therapy decision making and follow-up of biological therapies 2016 Lauri, Chiara; Auletta, S.; Carideo, Luciano; Valabrega, Stefano; Pacilio, Massimiliano; Signore, Alberto; Galli, Filippo
Lesion dosimetry and follow-up for a large group of castration-resistant prostate cancer (CRPC) patients and bone metastases treated with 223Ra therapy 2018 Pacilio, M.; Frantellizzi, V.; Verdolino, E.; Borrazzo, C.; Cassano, B.; Ventroni, G.; Mango, L.; De Vincentis, G.
Lesion dosimetry for Ra-223 therapy of bone metastases from castration-resistant prostate cancer: patients eligibility criterion and update of dosimetric assessments 2016 Pacilio, M; Cassano, B; De Vincentis, G; Ventroni, G; Frantellizzi, V; Follacchio, Ga; Pellegrini, R; Di Castro, E; Ialongo, P; Mango, L; Pani, R
Lesions dosimetry for 223Ra therapy of bone metastases from castration-resistant prostate cancer 2016 Pacilio, M.; Cassano, B.; Ventroni, G.; De Vincentis, G.; Pellegrini, R.; Di Castro, E.; Frantellizzi, V.; Follacchio, G. A.; Lorenzon, L.; Ialongo, P.; Mango, L.; Pani, R.
Myocardial blood flow estimates from dynamic contrast-enhanced magnetic resonance imaging: three quantitative methods 2018 Borrazzo, Cristian; Galea, Nicola; Pacilio, Massimiliano; Altabella, Luisa; Preziosi, Enrico; Carni, Marco; Ciolina, Federica; Vullo, Francesco; Francone, Marco; Catalano, Carlo; Carbone, Iacopo
Personalized dosimetry in the context of radioiodine therapy for differentiated thyroid cancer 2022 Pacilio, Massimiliano; Conte, Miriam; Frantellizzi, Viviana; De Feo, Maria Silvia; Pisani, Antonio Rosario; Marongiu, Andrea; Nuvoli, Susanna; Rubini, Giuseppe; Spanu, Angela; De Vincentis, Giuseppe
Psychological status and pain outcome evaluation in patients with painful bone metastases from castration resistant prostate cancer treated with 223Radium. 2016 Frantellizzi, V; Longo, F; Schinzari, G; Liberatore, M; Pacilio, M; Bianco, V; Follacchio, Ga; De Vincentis, G
Role of psychological status related to pain outcome and bone lesion dosimetry in patients with bone metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with 223Radium 2016 Frantellizzi, V; Follacchio, Ga; Cassano, B; Pacilio, M; Proietti, Franco; Pani, R; Pellegrini, R; De Vincentis, G
Role of tALP and ECOG Performance Status in predicting survival in mCRPC patients receiving 223Ra-dichloride 2017 Follacchio, Ga; Frantellizzi, V; Sollaku, S; DE FEO, MARIA SILVIA; Monteleone, F; Liberatore, M; Farcomeni, A; Pacilio, M; De Vincentis, G